$AMBA

AMBARELLA INC

CIK:0001280263|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025	Jul. 31, 2026	Jul. 31, 2025
Income Statement [Abstract]
Revenue	$ 108,125	$ 95,511	$ 208,482	$ 181,383
Cost of revenue	45,709	39,280	87,477	73,616
Gross profit	62,416	56,231	121,005	107,767
Operating expenses:
Research and development	50,581	59,734	108,721	118,553
Selling, general and administrative	19,978	18,486	39,843	37,061
Total operating expenses	70,559	78,220	148,564	155,614
Loss from operations	(8,143)	(21,989)	(27,559)	(47,847)
Other income, net	1,806	2,247	3,889	4,422
Loss before income taxes	(6,337)	(19,742)	(23,670)	(43,425)
Provision for income taxes	352	253	1,112	898
Net loss	$ (6,689)	$ (19,995)	$ (24,782)	$ (44,323)
Net loss per share attributable to ordinary shareholders:
Basic	$ (0.15)	$ (0.47)	$ (0.57)	$ (1.05)
Diluted	$ (0.15)	$ (0.47)	$ (0.57)	$ (1.05)
Weighted-average shares used to compute net loss per share attributable to ordinary shareholders:
Basic	44,005,576	42,546,979	43,805,429	42,383,475
Diluted	44,005,576	42,546,979	43,805,429	42,383,475

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025
Cash flows from operating activities:
Net loss	$ (24,782)	$ (44,323)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	12,840	13,384
Amortization (accretion) of premium (discount) on marketable debt securities, net	(74)	(128)
Stock-based compensation	44,593	51,318
Deferred income taxes	74	(174)
Other non-cash items, net	(120)	34
Changes in operating assets and liabilities:
Accounts receivable	1,740	(13,129)
Inventories	(24,557)	597
Prepaid expenses and other current assets	(1,018)	541
Other non-current assets	7	(48)
Accounts payable	(26,404)	7,252
Accrued and other current liabilities	(6,250)	1,195
Income taxes payable	778	330
Deferred revenue	(1,520)	5,307
Operating lease liabilities	(1,291)	(1,945)
Other long-term liabilities	98	96
Net cash provided by (used in) operating activities	(25,886)	20,307
Cash flows from investing activities:
Purchase of investments	(73,425)	(34,569)
Sales of investments	12,076	4,647
Maturities of investments	11,181	17,511
Purchase of tangible and intangible assets	(10,779)	(8,688)
Net cash used in investing activities	(60,947)	(21,099)
Cash flows from financing activities:
Share repurchase	(2,441)	(1,000)
Proceeds from exercise of stock options and employee stock purchase plan	5,929	4,893
Long-term financing payment for intangible assets	(5,824)	(4,549)
Net cash used in financing activities	(2,336)	(656)
Net decrease in cash, cash equivalents and restricted cash	(89,169)	(1,448)
Cash, cash equivalents and restricted cash at beginning of period	191,461	144,629
Cash, cash equivalents and restricted cash at end of period	102,292	143,181
Supplemental disclosure of cash flow information:
Cash paid for income taxes	416	838
Supplemental disclosure of noncash investing activities:
Unpaid liabilities related to tangible and intangible assets purchases	$ 1,783	$ 2,227

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jul. 31, 2026	Jan. 31, 2026
Current assets:
Cash and cash equivalents	$ 101,850	$ 191,019
Marketable debt securities	170,482	121,552
Accounts receivable, net	37,440	39,180
Inventories	76,923	52,246
Restricted cash	442	442
Prepaid expenses and other current assets	6,885	5,836
Total current assets	394,022	410,275
Property and equipment, net	12,061	11,553
Intangible assets, net	56,672	58,046
Operating lease right-of-use assets, net	10,923	12,118
Goodwill	303,625	303,625
Other non-current assets	2,902	2,983
Total assets	780,205	798,600
Current liabilities:
Accounts payable	26,478	54,029
Accrued and other current liabilities	86,490	97,964
Operating lease liabilities, current	2,229	2,027
Income taxes payable	2,309	1,531
Deferred revenue, current	20,865	22,393
Total current liabilities	138,371	177,944
Operating lease liabilities, non-current	10,413	11,408
Other long-term liabilities	11,105	14,459
Total liabilities	159,889	203,811
Commitments and contingencies (Note 14)	0	0
Shareholders' equity:
Preference shares, $0.00045 par value per share, 20,000,000 shares authorized and no shares issued and outstanding at July 31, 2026 and January 31, 2026, respectively	0	0
Ordinary shares, $0.00045 par value per share, 200,000,000 shares authorized; 44,140,961 and 43,305,592 shares issued and outstanding at July 31, 2026 and January 31, 2026, respectively	20	19
Additional paid-in capital	973,864	922,119
Accumulated other comprehensive income (loss)	(864)	573
Accumulated deficit	(352,704)	(327,922)
Total shareholders’ equity	620,316	594,789
Total liabilities and shareholders' equity	$ 780,205	$ 798,600